Qualibrate to Present at SAP Sapphire World Tour 2022

Qualibrate, the market-leading platform for SAP testing, training and documentation, to engage with and support the SAP community during this event.

Featured Image for Qualibrate

Featured Image for Qualibrate

AMSTERDAM, May 10, 2022 (GLOBE NEWSWIRE) — Qualibrate, the leading SaaS solution for SAP automation, announced today that the company will present at SAP Sapphire, Europe’s Premiere SAP Event, on May 17, 2022, at World Forum, The Hague, The Netherlands.

In February, Qualibrate achieved SAP certification for integration with SAP Solution Manager, which is one of the first steps toward building a long-lasting relationship with SAP and SAP technologies. SAP Sapphire will be another opportunity for Qualibrate to engage with and support the larger SAP ecosystem and community through its business process documentation and testing capabilities.

“Qualibrate is honored to be a part of SAP Sapphire and excited to show how our automation technology can truly enable digital transformation and help ease customers’ journeys to S4/HANA,” said Qualibrate Managing Director Alan Jimenez. “Automation is vital for business growth and efficiency and at Qualibrate, we have solutions that reduce effort and risk while increasing quality.”

Teams across organizations, such as IT and business, require solutions that can align their objectives. With Qualibrate, teams can rely on one single source of truth for reinventing the way teams test, document and train end-users.

Qualibrate provides a modern, cloud-native platform that enables customers to deliver S/4HANA more efficiently. Qualibrate also offers native support for non-SAP technologies, including Salesforce, ServiceNow and Others, allowing customers to automate their end-to-end business processes. Qualibrate provides a native integration with SAP Solution Manager, aligning to SAP best practices.

The Dutch Ministry of Defense (MoD), a Qualibrate customer and longtime user of test automation, will join Qualibrate at SAP Sapphire to share its success with the audience.

The MoD is constantly looking for ways to improve the efficiency of its IT processes while reducing costs. MoDs top priorities were finding a solution that was easy to learn, use and maintain. With Qualibrate, the MoD was able to:

  • increase its testing coverage to over 30 end-to-end complex scenarios that are now fully automated;
  • move from SAP releases every three months to every two weeks; and
  • save over 1500 hours for each technical release.

Qualibrate allows the MoD to test faster, document more efficiently and train its users more effectively on mission-critical systems without deep technical knowledge.

For more information, please visit https://www.qualibrate.com.

For more information on SAP Sapphire World Tour 2022, please visit: https://qa.go4.events.sap.com/sapsapphire/thehague

About Qualibrate:

Qualibrate is the 3-in-1 SaaS solution for enterprise software delivery that transforms the way teams test, document, and train end users. It offers native support for automating tests on SAP applications and 40+ non-SAP technologies such as Salesforce, Microsoft, ServiceNow, Oracle Cloud Apps, Mendix, etc.

Qualibrate’s Cloud test automation platform integrates natively with SAP Solution Manager Test Suite to extend the customer’s capability to automate SAP and non-SAP applications as part of their end-to-end testing strategy. Qualibrate is the tool of choice for customers such as AirFrance/KLM, Tommy Hilfiger, Calvin Klein, Bell Helicopter, Nouryon and more.

With a certified integration for SAP, your team can leverage Qualibrate to save up to 80% effort on testing and training while documenting business processes 7x faster than before.

Media Contact 

Mike Albanese
mike.albanese@newswire.com

Related Images


Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

Hitachi Energy launches game-changing power semiconductor module globally for all types of electric vehicles

High-performance power electronics take e-mobility to the next level and advance a more sustainable energy future for all

Zurich, Switzerland, May 10, 2022 (GLOBE NEWSWIRE) — Hitachi Energy, the global technology and market leader in power grids, today announced it will launch globally RoadPak, its pioneering power semiconductor module for electric vehicles at PCIM Europe, the world’s leading power electronics trade fair in Nuremberg, Germany, May 10-12.

RoadPak sets a new benchmark in electric vehicle performance. This compact module uses state-of-the-art silicon carbide (SiC) technology to achieve exceptional levels of power density for faster charging, reliability over the vehicle’s lifetime, and the lowest possible power losses for the longest possible driving range.

“RoadPak is the result of more than 100 years of Hitachi Energy innovation and market leadership in power electronics,” said Niklas Persson, Managing Director of Hitachi Energy’s Grid Integration business. “Along with our Grid-eMotion™ Flash and Fleet EV charging systems, it builds on our commitment to take e-mobility to the next level and advance a more sustainable energy future for all.”

Tested by many EV manufacturers and with two seasons of flawless performance with the Mahindra Racing Formula E team, RoadPak is available in both the 750 volt and 1,200 volt ranges. This makes it ideal for all types of electric vehicle – regular and luxury cars, commercial vehicles, buses, agricultural EVs, heavy-duty trucks and high-performance racing cars.

“We have had the privilege of piloting this advanced power module on our Mahindra M7Electro and M8Electro racing cars over the last two years, which has proven to significantly increase performance and reliability,” said Dilbagh Gill, CEO and Team Principal of Mahindra Racing. “This high technology improvement allows us to develop next-generation state-of-the-art green automotive solutions and improve driving experience.”

Power semiconductors are a critical component in electric vehicles. They are the heart of the inverter, which converts DC power from the vehicle’s battery into the AC power that drives the motor. Reliability is key. RoadPak semiconductors are designed to operate faultlessly for more than four million start-stop cycles over the vehicle’s lifetime.

The EV market is growing exponentially. Global sales of electric cars grew 40 percent in 2020 and almost doubled in 2021.1 In addition, all major car manufacturers have committed to phase out their petrol and diesel vehicles by 2030 or earlier.

Hitachi Energy has two separate manufacturing sources supporting security of supply worldwide for its SiC-based power semiconductor products, including RoadPak. The company makes its own SiC chips at its semiconductor factory in Switzerland and is supported by an independent SiC chip manufacturer in the United States, thereby securing supply in terms of both volumes and geographic availability.

Hitachi Energy’s advanced semiconductor technology is a key component in its grid integration solutions that enable vast amounts of renewable energy to flow reliably through power grids and between nations. They are also key to the traction converter systems that drive high-speed electric trains and metros, and the electric vehicles that are making road transportation clean and sustainable.

Notes to the Editor:

1. According to the International Energy Agency and World Economic Forum respectively: https://www.iea.org/news/global-electric-car-sales-set-for-further-strong-growth-after-40-rise-in-2020 and https://www.weforum.org/agenda/2022/02/electric-cars-sales-evs/.

About Hitachi Energy Ltd.

Hitachi Energy is a global technology leader that is advancing a sustainable energy future for all. We serve customers in the utility, industry and infrastructure sectors with innovative solutions and services across the value chain. Together with customers and partners, we pioneer technologies and enable the digital transformation required to accelerate the energy transition towards a carbon-neutral future. We are advancing the world’s energy system to become more sustainable, flexible and secure whilst balancing social, environmental and economic value. Hitachi Energy has a proven track record and unparalleled installed base in more than 140 countries. Headquartered in Switzerland, we employ around 38,000 people in 90 countries and generate business volumes of approximately $10 billion USD.

About Hitachi, Ltd.

Hitachi drives Social Innovation Business, creating a sustainable society with data and technology. We will solve customers’ and society’s challenges with Lumada solutions leveraging IT, OT (Operational Technology) and products, under the business structure of Digital Systems & Services, Green Energy & Mobility, Connective Industries and Automotive Systems. Driven by green, digital, and innovation, we aim for growth through collaboration with our customers. The company’s consolidated revenues for fiscal year 2021 (ended March 31, 2022) totaled 10,264.6 billions of yen (84,136 millions of U.S. dollars), with 853 consolidated subsidiaries and approximately 370,000 employees worldwide. For more information on Hitachi, please visit the company’s website at https://www.hitachi.com.

Attachments

Rebecca Bleasdale
Hitachi Energy Ltd.
+41 78643 2613
rebecca.bleasdale@hitachienergy.com

InDevR Launches Highly Multiplexed Kit for Rapid Pneumococcal Vaccine Characterization

Featured Image for InDevR, Inc.

Featured Image for InDevR, Inc.

BOULDER, Colo., May 10, 2022 (GLOBE NEWSWIRE) — InDevR, Inc., a life science tools company providing powerful analytical technologies to support the development and production of vaccines and biotherapeutics, announced the commercial availability of its VaxArray® Pneumococcal Assay Kit for rapid and accurate assessment of pneumococcal vaccines at all stages of manufacturing, including multivalent drug product. This launch is accompanied by the availability of a new and improved VaxArray software package that offers greater flexibility in experimental setup and data analysis.

InDevR’s powerful new pneumococcal assay, capable of simultaneous quantification of 23 high-priority serotypes in a single test, was developed with funding from the Bill & Melinda Gates Foundation using InDevR’s established VaxArray® Platform. Included in the kit are numerous monoclonal capture antibodies specifically developed by PATH and partners to improve standardization for future vaccine development and subsequently made available to the industry through a repository housed at the Medicines and Healthcare products Regulatory Agency site in South Mimms, UK, where NIBSC standards and research are developed. With this assay’s time to result of less than 30 minutes, the test offers substantial time, throughput, and labor savings over the singleplex technologies currently utilized in pneumococcal vaccine characterization. “We are thrilled to see these high-quality antibodies enable the development of critical technologies supporting characterization and manufacture of more effective and affordable pneumococcal vaccines,” states David Boyle, Laboratory Director, PATH Diagnostics program.

At the heart of the VaxArray Pneumococcal Assay is a microarray consisting of 23 monoclonal antibodies specific for high-priority serotypes in both on-market and in-development pneumococcal vaccines. The assay can be utilized to characterize both pneumococcal conjugate and pneumococcal polysaccharide samples from throughout development and manufacturing, including analysis of highly multivalent Drug Products. In addition, a number of detection labeling strategies are available — an optimized 23-valent polysaccharide labeling mixture for use with both monovalent and multivalent samples offers convenience, and individual detection labels can also be combined into a variety of custom mixtures as needed.

The VaxArray Pneumococcal Assay represents an exciting new tool for pneumococcal vaccine characterization, enabling global vaccine manufacturers to multiplex the quantification of numerous vaccine-relevant serotypes in a single test. Unlike many commonly utilized singleplex assays, the inherent multiplexing capabilities of the VaxArray Platform mean the Pneumococcal Assay can be utilized consistently to analyze polysaccharide content throughout manufacturing, release, and stability testing, and eliminate the requirement to bridge different analytics between drug substance and drug product.

Erica Dawson, CTO of InDevR, noted, “Our VaxArray Pneumococcal Kit represents a considerable leap forward in the ability to consistently and accurately identify, quantify, and assess stability for up to 23 high-priority serotypes in a single assay using an off-the-shelf kit. We are grateful to our PATH colleagues, as the assay is strengthened by inclusion of a variety of their high-performing, serotype-specific antibodies. Given the importance of pneumococcal conjugate vaccines in childhood vaccination schedules worldwide, we hope this assay can streamline analytical characterization of these critical vaccines for manufacturers around the globe, particularly to empower manufacturers in lower- and middle-income countries where significant efforts are underway to introduce new pneumococcal vaccines to the market.”

As InDevR’s first product offering for the bacterial vaccines market, the VaxArray Pneumococcal kit and updated software are high-impact additions to a growing portfolio of existing VaxArray products and services, consisting of a suite of off-the-shelf and custom antigen and serological kits for influenza, coronavirus, measles & rubella, and polio, as well as testing services.

Media Contact:

Terry Salyer, CCO

Phone: 650-520-8251

Email: salyer@indevr.com

Related Images

Image 1

This content was issued through the press release distribution service at Newswire.com.

Attachment

Nyxoah Reports First Quarter 2022 Financial and Operating Results

REGULATED INFORMATION

Nyxoah Reports First Quarter 2022 Financial and Operating Results

Mont-Saint-Guibert, Belgium – May 10, 2022, 08:50pm CET / 2:50pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH)(“Nyxoah” or the “Company”), a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA), today reported financial and operating results for the first quarter of 2022.

First Quarter 2022 Financial and Operating Highlights

  • Generated revenue of €660,000 from the commercialization of Genio® in Europe, primarily in Germany, which represents year-over-year growth of more than three-and-and-half times and is more than double what was achieved in the fourth quarter of 2021
  • Exited the first quarter with 15 active implant sites in Germany, representing 25% growth over Q4 2021; Nyxoah expects to add an extra 10 sites by the end of the third quarter of 2022, bringing the total to 25 active implanting accounts and driving quarterly sales acceleration and market leadership in Germany by the end of 2022
  • Completed the first commercial Complete Concentric Collapse (CCC) patients in Germany
  • Accelerated monthly patient enrollment in the DREAM U.S. IDE study and continue to expect implants to be completed in the second quarter of 2022
  • The U.S. FDA approved Nyxoah’s request to reduce the sample size in DREAM to 115 patients from the original 134, driven by new and favorable data from the BETTER SLEEP study; aside from the updated sample size, all other study parameters, including performance goals, statistical power, and significance level, remain identical to the original approved study
  • Nominated Raymond Cohen, Chief Executive Officer and board member of Axonics, Inc. and Virginia Kirby, Executive-in-Residence at the Discovery Launchpad at the University of Minnesota’s Office of Technology Commercialization, for appointment to the Board of Directors, pending approval by the Annual Shareholders’ Meeting on June 8, 2022; Don Deyo and Jan Janssen are stepping down, keeping the total number of board members at eight

“I am extremely pleased with our first quarter results and strong execution that resulted in an acceleration in sales and DREAM implants as we progress towards achieving all of our strategic priorities for 2022 and beyond,” commented Olivier Taelman, Nyxoah’s Chief Executive Officer. “On the commercial side, the €660,000 of revenue we booked in the first quarter was roughly equal to the revenue performance from the previous three quarters combined. We now have 15 active implant sites in Germany, and we will continue to add 10 more sites by the end of the third quarter. This growth validates our patient-centric, ‘Going Deep’ strategy of developing Centers of Excellence as we increase therapy penetration at each of these sites. We were also thrilled to implant our first commercial CCC patients in Germany, and we expect continued acceleration in CCC implants following the positive response to our BETTER SLEEP data presentation at the World Sleep Congress in Rome, where we hosted 55 key opinion leaders during the pre-Congress symposium.”

Mr. Taelman continued, “We are also happy with the acceleration in the pace of implants in our DREAM U.S. pivotal study, given recent weekly implant rates, which have increased meaningfully over the last month. We believe we have enough patients enrolled to complete the study by the end of the second quarter of 2022, particularly in light of the FDA’s approval to reduce the sample size to 115 patients. We also continue our dialogue with FDA regarding our IDE submission for our ACCCESS trial for CCC patients in the U.S., and we expect to implant our first patient before the end of this year.”

“Finally, I am thrilled to announce the nominations of Ray Cohen and Ginny Kirby for appointment to the Board of Directors. They will bring a wealth of knowledge that will benefit Nyxoah as we complete DREAM, prepare for our U.S. launch, and advance our pipeline. I look forward to working closely with both of them,” concluded Mr. Taelman.

First Quarter 2022 Results

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS AT AND FOR THE THREE MONTHS ENDED MARCH 31, 2022 – INTERIM CONSOLIDATED STATEMENTS OF LOSS AND OTHER COMPREHENSIVE LOSS (IN THOUSANDS)

        For the three months ended March 31
Notes 2022   2021
       
Revenue €  660 €  185
Cost of goods sold   ( 289) ( 52)
Gross profit €  371 €  133
Research and Development Expense   (3 595) (3 094)
Selling, General and Administrative Expense (4 193) (2 366)
Other income/(expense) 136 4
Operating loss for the period   € (7 281) € (5 323)
Financial income 1 576 4
Financial expense   ( 788) ( 325)
Loss for the period before taxes € (6 493) € (5 644)
Income taxes   ( 208) ( 25)
Loss for the period € (6 701) € (5 669)
     
Loss attributable to equity holders € (6 701) € (5 669)
Other comprehensive loss  
Items that may be subsequently reclassified to profit or loss (net of tax)
Currency translation differences   ( 102) ( 70)
Total comprehensive loss for the year, net of tax € (6 803) € (5 739)
Loss attributable to equity holders   € (6 803) € (5 739)
Basic Loss Per Share (in EUR) € (0.260) € (0.256)
Diluted Loss Per Share (in EUR) € (0.260) € (0.256)

The accompanying notes are an integral part of these condensed consolidated interim financial statements

 

UNAUDITED CONSOLIDATED BALANCESHEET (in thousands)

        As at
March 31 2022   December 31 2021
ASSETS
Non-current assets        
Property, plant and equipment € 2 048 € 2 020
Intangible assets 28 526   25 322
Right of use assets 3 154 3 218
Deferred tax asset     529   46
Other long-term receivables 165 164
    € 34 422   € 30 770
Current assets      
Inventory     301   346
Trade receivables 619 226
Other receivables     1 607   2 286
Other current assets 1 197 1 693
Financial assets 45 041
Cash and cash equivalents 82 787 135 509
  € 131 552 € 140 060
Total assets € 165 974 € 170 830
   
EQUITY AND LIABILITIES
Capital and reserves    
Capital 4 432 4 427
Share premium 228 158   228 033
Share based payment reserve   3 788 3 127
Other comprehensive income 100   202
Retained loss   (93 864) (87 167)
Total equity attributable to shareholders € 142 614 € 148 622
     
LIABILITIES
Non-current liabilities    
Financial debt 7 952   7 802
Lease liability   2 664 2 737
Pension liability 80   80
Provisions   22 12
Deferred tax liability   5
€ 10 718 € 10 636
Current liabilities    
Financial debt 598   554
Lease liability   599 582
Trade payables 3 401   3 995
Current tax liability 3 588   2 808
Other payables 4 456   3 633
  € 12 642 € 11 572
Total liabilities € 23 360 € 22 208
Total equity and liabilities € 165 974 € 170 830

UNAUDITED CONDENSED CONSOLIDATED INTERIM FINANCIAL STATEMENTS AS AT AND FOR THE THREE MONTHS ENDED MARCH 31, 2022 – INTERIM CONSOLIDATED STATEMENTS OF CASH FLOWS (IN THOUSANDS)

        For the three months ended March 31
2022   2021
CASH FLOWS FROM OPERATING ACTIVITIES
Loss before tax for the year       € (6 493)   € (5 644)
Adjustments for
Finance income (1 576) ( 4)
Finance expenses 788 325
Depreciation and impairment of property, plant and equipment and right-of-use assets 255 164
Amortization of intangible assets 208 211
Share-based payment transaction expense 665
Increase/(decrease) in provisions 10
Other non-cash items 180 3
Cash generated before changes in working capital € (5 963) € (4 945)
Changes in working capital
Decrease/(Increase) in inventory 45 ( 51)
(Increase)/decrease in trade and other receivables 884 (1 195)
Increase/(Decrease) in trade and other payables ( 392) 2 170
Cash generated from changes in operations € (5 426) € (4 021)
Interests received 1
Income tax paid (65) (34)
Net cash used in operating activities € (5 491) € (4 054)
CASH FLOWS FROM INVESTING ACTIVITIES
Purchases of property, plant and equipment ( 128) ( 169)
Capitalization of intangible assets (3 412) (1 606)
(Increase)/decrease in financial assets – current (44 032)
Net cash used in investing activities € (47 572) € (1 775)
CASH FLOWS FROM FINANCING ACTIVITIES
Payment of principal portion of lease liabilities ( 146) ( 135)
Repayment of other loan ( 21) ( 21)
Interests paid ( 109) ( 105)
Proceeds from issuance of shares, net of transaction costs 130 52
Other financial costs (2)
Net cash generated from financing activities € ( 148) € ( 209)
Movement in cash and cash equivalents € (53 211) € (6 038)
Effect of exchange rates on cash and cash equivalents 489 ( 55)
Cash and cash equivalents at January 1 € 135 509 € 92 300
Cash and cash equivalents at March 31 € 82 787 € 86 207

Revenue

Revenue was €660,000 for the first quarter ending March 31, 2022, compared to €185,000 for the first quarter ending March 31, 2021. The increase in revenue was attributable to the Company’s commercialization of the Genio® system, primarily in Germany.

Cost of Goods Sold

Cost of goods sold was €289,000 for the three months ending March 31, 2022, representing a gross profit of €371,000, or gross margin of 56.2%.

Research and Development Expenses

Research and Development expenses were €3.6 million for the three months ending March 31, 2022, versus €3.1 million for the prior year period, reflecting the Company’s investments in the development of next generation versions of the Genio® system as well as ongoing clinical studies, most notably DREAM in the U.S.

Selling, General and Administrative Expenses

General and administrative expenses rose to €4.2 million for the first quarter of 2022, up from €2.4 million in the first quarter of 2021. This was due primarily to increased commercial efforts in Germany and other European markets, as well as investments in Nyxoah’s corporate infrastructure. The Company expects to continue adding headcount across the organization ahead of U.S. commercial launch.

Operating Loss

Total operating loss for the first quarter of 2022 was €7.3 million versus €5.3 million in the first quarter of 2021, driven by the acceleration in our R&D spending, as well as ongoing commercial and clinical activities. Nyxoah realized a net loss of €6.7 million for the quarter ended March 31, 2022, compared to a net loss of €5.7 million for the quarter ended March 31, 2021.

Cash Position
As of March 31, 2022, cash and financial assets totaled €127.8 million on March 31, 2022, compared to €135.5 million on December 31, 2021. Total cash burn was approximately €2.6 million per month during the first quarter of 2022. Nyxoah expects monthly cash burn to increase slightly as the year progresses to account for the commencement of the ACCCESS IDE trial in the U.S., and current cash position provides ample liquidity to get to U.S. commercialization in 2024.

First Quarter 2022 Report
Nyxoah’s financial report for the first quarter of 2022, including details of the consolidated results, are available on the investor page of Nyxoah’s website (https://investors.nyxoah.com/financials).

Conference call and webcast presentation 
Nyxoah will conduct a conference call open to the public tomorrow, May 10, 2022, at 2:00 p.m. CET / 8:00 a.m. ET, which will also be webcasted. To participate in the conference call, please dial one of the following numbers:

Conference ID: 8444917

USA:                             (844) 260-3718
Belgium:                       0800 73264
International:                (929) 517-0938

A question-and-answer session will follow the presentation of the results. To access the live webcast, go to https://investors.nyxoah.com/events. The archived webcast will be available for replay shortly after the close of the call.

About Nyxoah
Nyxoah is a medical technology company focused on the development and commercialization of innovative solutions to treat Obstructive Sleep Apnea (OSA). Nyxoah’s lead solution is the Genio® system, a patient-centered, leadless and battery-free hypoglossal neurostimulation therapy for OSA, the world’s most common sleep disordered breathing condition that is associated with increased mortality risk and cardiovascular comorbidities. Nyxoah is driven by the vision that OSA patients should enjoy restful nights and feel enabled to live their life to its fullest.

Following the successful completion of the BLAST OSA study, the Genio® system received its European CE Mark in 2019. Nyxoah completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021. Following the positive outcomes of the BETTER SLEEP study, Nyxoah received CE mark approval for the expansion of its therapeutic indications to Complete Concentric Collapse (CCC) patients, currently contraindicated in competitors’ therapy. Additionally, the Company is currently conducting the DREAM IDE pivotal study for FDA and US commercialization approval.

For more information, please visit http://www.nyxoah.com/.

Caution – CE marked since 2019. Investigational device in the United States. Limited by U.S. federal law to investigational use in the United States.

Forward-looking statements 
Certain statements, beliefs and opinions in this press release are forward-looking, which reflect the Company’s or, as appropriate, the Company directors’ or managements’ current expectations regarding the Genio® system; planned and ongoing clinical studies of the Genio® system; the potential advantages of the Genio® system; Nyxoah’s goals with respect to the development, regulatory pathway and potential use of the Genio® system; the utility of clinical data in potentially obtaining FDA approval of the Genio® system; and the Company’s results of operations, financial condition, liquidity, performance, prospects, growth and strategies. By their nature, forward-looking statements involve a number of risks, uncertainties, assumptions and other factors that could cause actual results or events to differ materially from those expressed or implied by the forward-looking statements. These risks, uncertainties, assumptions and factors could adversely affect the outcome and financial effects of the plans and events described herein. Additionally, these risks and uncertainties include, but are not limited to, the risks and uncertainties set forth in the “Risk Factors” section of the Company’s Annual Report on Form 20-F for the year ended December 31, 2021, to be filed with the Securities and Exchange Commission (“SEC”) on March 24, 2022, and subsequent reports that the Company files with the SEC. A multitude of factors including, but not limited to, changes in demand, competition and technology, can cause actual events, performance or results to differ significantly from any anticipated development. Forward looking statements contained in this press release regarding past trends or activities are not guarantees of future performance and should not be taken as a representation that such trends or activities will continue in the future. In addition, even if actual results or developments are consistent with the forward-looking statements contained in this press release, those results or developments may not be indicative of results or developments in future periods. No representations and warranties are made as to the accuracy or fairness of such forward-looking statements. As a result, the Company expressly disclaims any obligation or undertaking to release any updates or revisions to any forward-looking statements in this press release as a result of any change in expectations or any change in events, conditions, assumptions or circumstances on which these forward-looking statements are based, except if specifically required to do so by law or regulation. Neither the Company nor its advisers or representatives nor any of its subsidiary undertakings or any such person’s officers or employees guarantees that the assumptions underlying such forward-looking statements are free from errors nor does either accept any responsibility for the future accuracy of the forward-looking statements contained in this press release or the actual occurrence of the forecasted developments. You should not place undue reliance on forward-looking statements, which speak only as of the date of this press release.

Contacts:
Nyxoah
Loic Moreau, Chief Financial Officer
corporate@nyxoah.com
+32 473 33 19 80

Jeremy Feffer, VP IR and Corporate Communications
jeremy.feffer@nyxoah.com
+1 917 749 1494

Attachment

LeddarTech Releases Its LeddarSteer Automotive-Grade, Solid-State Digital Beam Steering Technology for LiDAR Sensor Developers

LeddarSteer DBS

LeddarSteer DBS by LeddarTech

QUEBEC, May 10, 2022 (GLOBE NEWSWIRE) — LeddarTech®, a global leader in providing the most flexible, robust and accurate ADAS and AD sensing technology, is pleased to announce the official release of LeddarSteer™, a digital beam steering solution designed for LiDAR smart sensor developers and Tier 1-2 automotive suppliers.

Digital beam steering refers to changing the direction of laser pulses in a LiDAR. Using a stack of alternating liquid crystal cells and polarization gratings enables to steer light at different angles at a specific wavelength in order to augment a LiDAR field of view while maximizing its performance, allowing digital beam steering for LiDAR to be achieved.

LeddarSteer digital beam steering offers a myriad of benefits to LiDAR smart sensor developers and Tier 1 and 2 customers, including:

  • Software-controlled on-the-fly adjustment
    • Frame-by-frame adjustment
    • Preset or customized configuration
    • Easy setup and interface
    • Voltage-controlled steering
  • Multiple LiDAR applications
    • Compatible with a wide range of LiDAR architectures
    • Enables one LiDAR to address multiple use cases
    • Field of view adjustable for various actions, including turns, exits, lane changes and slopes
    • Same LiDAR for highway and city driving
    • Reduces the number of sensors, generating cost savings
  • Automotive-grade solid-state technology, resulting in a significantly higher MTBF (mean time between failures)

LeddarSteer can be seamlessly integrated into an existing LiDAR to expand the field of view or integrated into new LiDAR development. The solution provides an enhanced signal-to-noise ratio by concentrating laser power on a small region of interest while reducing the size, cost and complexity of LiDAR components whilst maintaining or increasing the pixel count and resolution.

“For well over a decade, LeddarTech has been a leader in developing sensing solutions that enable our customers to deliver high-performance ADAS and AD sensors,” stated Mr. Charles Boulanger, CEO of LeddarTech. “LeddarSteer is the only digital beam steering smart component designed for mass production with the flexibility, reliability, cost, size and performance required by the most demanding 3D sensing applications and supported by standard automotive manufacturing process,” concluded Mr. Boulanger.

About LeddarTech

Founded in 2007, LeddarTech is a comprehensive end-to-end environmental sensing company that enables customers to solve critical sensing, fusion and perception challenges across the entire value chain. LeddarTech provides cost-effective perception solutions scalable from Level 2 ADAS to Level 5 full autonomy with LeddarVision™, a raw-data sensor fusion and perception platform that generates a comprehensive 3D environmental model from a variety of sensor types and configurations. LeddarTech also supports LiDAR manufacturers and Tier 1-2 automotive suppliers with key technology building blocks such as LeddarSteer™ digital beam steering and the LeddarEngine™, which is built on LeddarTech’s Leddar™ technology employing patented signal acquisition and processing techniques to generate a richer and cleaner return signal at a lower cost. The LeddarEngine comprises a highly integrated, scalable LiDAR SoC and software combination that enables LiDAR developers and Tier 1-2 automotive suppliers to design their own LiDAR solutions. The company is responsible for several innovations in cutting-edge automotive and mobility remote-sensing applications, with over 120 patents granted or applied for, enhancing ADAS and autonomous driving capabilities.

Additional information about LeddarTech is accessible at www.leddartech.com and on LinkedIn, Twitter, Facebook and YouTube.

Contact:
Daniel Aitken, Vice-President, Global Marketing, Communications and Investor Relations, LeddarTech Inc.
Tel.: + 1-418-653-9000 ext. 232 daniel.aitken@leddartech.com

Investor relations contact: InvestorRelations@leddartech.com
https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator and related logos are trademarks or registered trademarks of LeddarTech Inc. and its subsidiaries. All other brands, product names and marks are or may be trademarks or registered trademarks used to identify products or services of their respective owners.

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/75f154a6-27b8-4546-8614-00d3885feef0

A video accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/95010106-6e76-4996-ac0a-3c68c7c09d3d


Copyright © 2022 GlobeNewswire, Inc.

LeddarTech เปิดตัว LeddarSteer ซึ่งเป็นเทคโนโลยีการบังคับเลี้ยวด้วยลำแสงดิจิทัลแบบโซลิดสเตตเกรดยานยนต์สำหรับนักพัฒนาเซ็นเซอร์ LiDAR

ควิเบก, May 10, 2022 (GLOBE NEWSWIRE) — LeddarTech® ผู้นำระดับโลกในการจัดหาเทคโนโลยี การตรวจจับ ADAS และ AD ที่ยืดหยุ่น แข็งแกร่ง และแม่นยำที่สุด ยินดีที่จะประกาศเปิดตัว LeddarSteer™ อย่างเป็นทางการ ซึ่งเป็นโซลูชันการบังคับเลี้ยวด้วยลำแสงดิจิทัลที่ออกแบบมาสำหรับนักพัฒนาเซ็นเซอร์อัจฉริยะ LiDAR และซัพพลายเออร์ยานยนต์ระดับ 1-2

การบังคับเลี้ยวด้วยลำแสงดิจิทัลหมายถึงการเปลี่ยนทิศทางของพัลส์เลเซอร์ใน LiDAR การใช้เซลล์คริสตัลเหลวสลับกันและตะแกรงโพลาไรซ์ช่วยให้บังคับทิศทางแสงในมุมต่าง ๆ ที่ความยาวคลื่นเฉพาะ เพื่อเพิ่มขอบเขตการมองเห็นของ LiDAR ควบคู่ไปกับการเพิ่มประสิทธิภาพของมันให้สูงสุด ซึ่งทำให้ LiDAR สามารถใช้การบังคับเลี้ยวด้วยลำแสงดิจิทัลได้สำเร็จ

การบังคับเลี้ยวด้วยลำแสงดิจิทัลของ LeddarSteer มีประโยชน์มากมายสำหรับนักพัฒนาเซ็นเซอร์อัจฉริยะ LiDAR และลูกค้าระดับ 1 และ 2 ซึ่งรวมถึง:

  • การปรับในขณะที่ยานพาหนะกำลังแล่นที่ควบคุมโดยซอฟต์แวร์
    • การปรับแบบเฟรมต่อเฟรม
    • การกำหนดค่าแบบกำหนดเองหรือกำหนดค่าตามที่มีไว้ให้แล้ว
    • การตั้งค่าและอินเทอร์เฟซที่ง่ายดาย
    • และพวงมาลัยซึ่งควบคุมด้วยแรงดันไฟฟ้า
  • แอปพลิเคชัน LiDAR
    • หลายรายการนั้นมีความเข้ากันได้กับสถาปัตยกรรม LiDAR
    • ที่หลากหลาย ซึ่งทำให้ LiDAR หนึ่งรายการสามารถจัดการกับการใช้งานได้ในหลาย ๆ กรณี
    • อีกทั้งยังมีขอบเขตการมองเห็นที่ปรับได้สำหรับการดำเนินการต่าง ๆ ซึ่งรวมถึงการเลี้ยว การออก การเปลี่ยนเลนและการวิ่งบนทางลาด
    • นอกจากนี้ การใช้ LiDAR เดียวกันสำหรับการขับขี่บนทางหลวงและในเมืองก็ช่วยลดจำนวนเซ็นเซอร์ลง
    • ทำให้ประหยัดค่าใช้จ่ายอีกด้วย
  • เทคโนโลยีโซลิดสเตตเกรดยานยนต์ ส่งผลให้ MTBF สูงขึ้นอย่างมีนัยสำคัญ (หมายถึงระยะเวลาเฉลี่ยก่อนการเสียหายแต่ละครั้งหรือ time between failures)

LeddarSteer สามารถรวมเข้ากับ LiDAR ที่มีอยู่ได้อย่างราบรื่นเพื่อช่วยในการขยายขอบเขตการมองเห็น หรือรวมเข้ากับการพัฒนา LiDAR ใหม่ ๆ ก็ได้เช่นกัน โซลูชันนี้ช่วยปรับปรุงอัตราส่วนสัญญาณต่อสัญญาณรบกวนโดยใช้การเน้นพลังงานเลเซอร์ในพื้นที่เล็ก ๆ ที่สนใจ ควบคู่ไปกับการลดขนาด ค่าใช้จ่าย และความซับซ้อนของส่วนประกอบ LiDAR ในขณะที่ยังคงรักษาหรือเพิ่มจำนวนพิกเซลและความละเอียดเอาไว้ได้

Charles Boulanger ซีอีโอของ LeddarTech กล่าวว่า “กว่าทศวรรษแล้วที่ LeddarTech ได้เป็นผู้นำในการพัฒนาโซลูชันการตรวจจับที่ช่วยให้ลูกค้าของเราสามารถส่งมอบเซ็นเซอร์ ADAS และ AD ต่าง ๆ ที่มีประสิทธิภาพสูง” และสุดท้าย คุณ Boulanger ก็ได้กล่าวสรุปว่า “LeddarSteer เป็นส่วนประกอบอัจฉริยะในการบังคับเลี้ยวด้วยลำแสงดิจิทัลเพียงชิ้นเดียวที่ออกแบบมาสำหรับการผลิตจำนวนมาก โดยมีทั้งความยืดหยุ่น ความน่าเชื่อถือ ราคา ขนาด และประสิทธิภาพที่แอปพลิเคชันการตรวจจับ 3 มิติที่มีความต้องการมากที่สุดนั้นต้องการ อีกทั้งยังได้รับการสนับสนุนจากกระบวนการผลิตยานยนต์มาตรฐานอีกด้วย”

เกี่ยวกับ LeddarTech

LeddarTech ก่อตั้งขึ้นในปี 2007 โดยเป็นบริษัทตรวจจับข้อมูลด้านสิ่งแวดล้อมแบบครบวงจรที่ครอบคลุม ซึ่งช่วยให้ลูกค้าสามารถแก้ปัญหาด้านการตรวจจับ การฟิวชัน และการรับรู้ที่สำคัญตลอดทั้งห่วงโซ่คุณค่า LeddarTech มอบโซลูชันการรับรู้ที่คุ้มค่าซึ่งปรับขนาดได้ตั้งแต่ ADAS ระดับ 2 ไปจนถึงระดับ 5 แบบอิสระเต็มรูปแบบด้วย LeddarVision™ ซึ่งเป็นฟิวชันเซ็นเซอร์ข้อมูลดิบและแพลตฟอร์มการรับรู้ที่สร้างแบบจำลองสภาพแวดล้อม 3 มิติที่ครอบคลุมจากเซ็นเซอร์และการกำหนดค่าหลากหลายประเภท LeddarTech ยังสนับสนุนผู้ผลิต LiDAR และซัพพลายเออร์ยานยนต์ระดับ 1-2 ด้วยบล็อกสิ่งก่อสร้างทางเทคโนโลยีหลัก เช่น ระบบบังคับเลี้ยวด้วยลำแสงดิจิทัล LeddarSteer™ และ LeddarEngine™ ซึ่งสร้างขึ้นบนเทคโนโลยี Leddar™ ของ LeddarTech โดยใช้การรับสัญญาณที่จดสิทธิบัตรและเทคนิคการประมวลผลเพื่อสร้างสัญญาณย้อนกลับที่ที่ชัดเจนและสมบูรณ์ยิ่งขึ้นด้วยต้นทุนที่น้อยลง LeddarEngine ประกอบด้วย LiDAR SoC และการรวมกันของซอฟต์แวร์ที่มีรูปแบบการผสมผสานที่สูงและสามารถปรับขนาดได้ ซึ่งช่วยให้นักพัฒนา LiDAR และซัพพลายเออร์ยานยนต์ระดับ 1-2 สามารถออกแบบโซลูชัน LiDAR ของตนเองได้ บริษัทเป็นผู้รับผิดชอบในการคิดค้นนวัตกรรมใหม่ ๆ ในแอปพลิเคชันตรวจจับยานยนต์และการเคลื่อนที่ระยะไกลที่ทันสมัยด้วยเทคโนโลยีที่จดสิทธิบัตรมากกว่า 120 รายการ (ทั้งที่จดสิทธิบัตรแล้วหรือรอดำเนินการ) ที่ช่วยเสริมขีดความสามารถ ADAS และการขับขี่แบบอัตโนมัติ

ดูข้อมูลเพิ่มเติมเกี่ยวกับ LeddarTech ได้ที่ www.leddartech.com และบน ลิงกต์อิน, ทวิตเตอร์, เฟซบุ๊ก และ ยูทูบ

ติดต่อ:Daniel Aitken รองประธาน ฝ่ายการตลาดระดับโลก ฝ่ายการสื่อสารและนักลงทุนสัมพันธ์ของ LeddarTech Inc.โทร.: +1-418-653-9000 ต่อ 232 daniel.aitken@leddartech.com

ติดต่อนักลงทุนสัมพันธ์:InvestorRelations@leddartech.com                https://investors.leddartech.com/

Leddar, LeddarTech, LeddarSteer, LeddarEngine, LeddarVision, LeddarSP, LeddarCore, LeddarEcho, VAYADrive, VayaVision, XLRator และโลโก้ที่เกี่ยวข้องเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนของ LeddarTech Inc. และบริษัทในเครือ แบรนด์ ชื่อผลิตภัณฑ์ และเครื่องหมายอื่น ๆ ทั้งหมดเป็นหรืออาจเป็นเครื่องหมายการค้าหรือเครื่องหมายการค้าจดทะเบียนที่ใช้เพื่อระบุผลิตภัณฑ์หรือบริการของเจ้าของที่เกี่ยวข้อง

รูปภาพประกอบของการแถลงนี้สามารถรับชมได้ที่: https://www.globenewswire.com/NewsRoom/AttachmentNg/75f154a6-27b8-4546-8614-00d3885feef0

วิดีโอประกอบของข่าวประชาสัมพันธ์นี้สามารถดูได้ที่: https://www.globenewswire.com/NewsRoom/AttachmentNg/95010106-6e76-4996-ac0a-3c68c7c09d3d

Leading Centralized Exchange, AscendEX Lists Enjin Token ($ENJ) and Efinity Token ($EFI)

SINGAPORE, May 09, 2022 (GLOBE NEWSWIRE) — Today, AscendEX is excited to announce the forthcoming listing of two tokens, the Enjin token (ENJ) under the trading pair (ENJ/USDT) and the Efinity token (EFI) under the trading pair (EFI/USDT) on May 10th at 1 P.M UTC.

Launched in 2018, AscendEX is a global cryptocurrency exchange, servicing over 1 million retail and institutional clients globally, through its comprehensive product suite including spot, margin, and futures trading, wallet services, and staking support for over 200 blockchain projects such as bitcoin, ether, and ripple. With both Enjin and Efinity built on Polkadot, AscendEX signals an entry point for investors looking to get involved in the Polkadot ecosystem.

Enjin’s Platform Powering Digital Assets

Enjin is a product ecosystem that is helping create advanced virtual economies through the power of blockchain technology. The Enjin Platform, Wallet, Marketplace, Explorer, and Beam make up an integrated blockchain ecosystem, and provide the tools and solutions developers and businesses need to tokenize NFTs and integrate them into software. Enjin’s blockchain ecosystem supports projects across gaming, metaverse, virtual reality, collectibles, digital fashion and more. Pioneering creators, developers, and companies like Microsoft (Azure Heroes), Samsung (Samsung Blockchain Keystore), and BMW (Vantage), have integrated Enjin’s products and services already.

With Enjin, users can create as many wallets as they need, from a daily expense or savings wallet to a dedicated wallet for blockchain gaming and trading NFTs. Users can import old wallets and easily track hardware wallets, like Trezor or Ledger.

As of July 2021, ENJ had a market cap of $1.5 billion, with over $800 million held by more than 125,000 ENJ token holders worldwide. ENJ recently made headlines as the first gaming token to be approved for use in Japan under the JVCEA, after receiving approval from Japan’s financial regulators to be listed on CoinCheck in January 2021.

Efinity’s Purpose-built NFT Experience
In collaboration with the Web3 Foundation, the Enjin platform is being used to power Efinity, a next-generation blockchain for NFT, built on Polkadot. Efinity is not a general computing blockchain, but a NFT highway that prioritizes Token creation, transfers, and purchases on the network. A benefit to using Efinity’s platform is their focus on allowing users to experience their favorite collectibles, without worrying about transaction fees and how the network operates.

The Challenge with the NFT Landscape
The current landscape requires Creators to work with crippling fees, inflexible smart contracts and disjointed interoperability and adoption of NFTs is still limited to crypto enthusiasts. The blockchains that non-fungible tokens live on give actual users no incentives, because miners are given the full share of generated tokens. Prices rise, infrastructure companies create silos and paywalls, and it becomes difficult to make real progress in this industry. Efinity was built to solve these problems, by compensating network participants with the EFI token.

Businesses and developers require a platform that can deliver a modern, mainstream and developer-friendly NFT experience. Since the release of Ethereum, there have been attempts to build infrastructure and tokenization around this general-purpose computing blockchain, but there continues to be an ever-growing desire for a better solution.

Efinity’s Solution to Enhance the NFT Experience
Efinity will be a hub for all fungible and non-fungible tokens. The Efinity blockchain is a parachain that uses Polkadot Relay Chain validators for its consensus, which allows Efinity to have an independent economic framework, data, and state. The Paratoken standard accepts tokens from any other chain, including the popular ERC-721, ERC-1155, and ERC-20 standards. The network that solves the challenge of facilitating the pricing and exchange of NFTs will naturally gain traction because it will create network effects by attracting increasing volumes of transactions. Tokens don’t need to be listed for sale or even exist on the network to receive a bid. In fact, users can be compensated for initiating Bid Orders or Ask Orders and stimulating network usage by initiating transactions which may be completed by other users.

This mechanism will naturally attract buyers and sellers to join the platform and create network effects by incentivizing users to initiate transactions. This functionality is intended to be further developed by third party apps that facilitate transfers within other platforms including games that function as NFT Marketplaces.

For more information and updates on AscendEX, please visit:

Website: ascendex.com
Twitter: twitter.com/AscendEX_Global
Telegram: t.me/AscendEXEnglish
Medium: medium.com/ascendex

For more information and updates about Enjin, please visit:

Website: enjin.io/
Twitter: twitter.com/enjin
Telegram: t.me/enjin

For more information and updates about Efinity, please visit:

Website: efinity.io/
Twitter: twitter.com/efinityio

Media Contact:
ryleigh@serotonin.co
+16476466270

Synchronoss to Provide Wholesale Process Automation and Management to Brightspeed

Relationship to Support Brightspeed’s Planned Fiber Deployments Across 20-State Footprint

Multi-Year Agreement Features interconnectNOW and Financial Analytics
to Help Orchestrate Service Requests and Manage Trading Partner Expense

BRIDGEWATER, N.J., May 09, 2022 (GLOBE NEWSWIRE) — Synchronoss Technologies Inc. (“Synchronoss” or the “Company”) (Nasdaq: SNCR), a global leader and innovator in cloud, messaging and digital products and platforms, today announced that it has signed a multi-year agreement with Brightspeed, a provider of broadband and telecommunications services expected to have operations in 20 States. Brightspeed will initially be comprised of the incumbent local exchange carrier (ILEC) assets and associated operations of Lumen Technologies (NYSE: LUMN), which are the subject of a pending acquisition by Apollo-managed funds (NYSE: APO).

Brightspeed will utilize two key modules from the Synchronoss networkX Platform – interconnectNOW (iNOW) and Financial Analytics (FA) – for its planned fiber deployments throughout its multi-state territory across rural and suburban regions of the United States.

Brightspeed previously announced plans to invest more than $2 billion to build a network that will bring faster, more reliable Internet and Wi-Fi to communities throughout the Midwest, Southeast, and certain parts of Pennsylvania and New Jersey.   The company’s planned fiber optics transformation is expected to reach up to three million homes and businesses over the next five years, including in many places where fiber and advanced technology have not historically been deployed.

“As Brightspeed continues to build out its fiber optics network, iNOW and Financial Analytics will be integral in managing the company’s wholesale carrier operations,” said Chris Hill, Chief Commercial Officer at Synchronoss. “Automating and orchestrating orders throughout the lifecycle will enable Brightspeed to keep pace with customer requests and realize revenue faster.”

“Our partnership with Synchronoss will provide us access to their state-of-the-art platforms to achieve exceptional efficiencies in managing our wholesale carrier orders and trading partner transactions,” said Chris Creager, Chief Administration Officer of Brightspeed. “From end-to-end, iNOW will enable us to track orders and help us deliver world-class connectivity products and services to the communities we look forward to serving.”

The iNOW platform eliminates manual handling of service orders and manages the full lifecycle between customer and supplier via automation and rules-based validation. It provides a single interface and database for all buyer and supplier orders, making it easy to track orders from receipt to fulfillment, reconciles billing, and provides real-time reporting – shortening time to revenue.

The Financial Analytics platform streamlines the management of complex carrier invoicing via automated workflow and intuitive rules engines for auditing, accounting, validation, and payment of invoices. FA empowers service providers such as Brightspeed with the necessary tools and processes to ensure intercarrier expenses are thoroughly analyzed and confirmed prior to payment.

Leading service providers from around the world utilize Synchronoss and the iNOW platform to manage 39 million orders and transactions annually from 5,000 integrated operators.

About Synchronoss

Synchronoss Technologies (Nasdaq: SNCR) builds software that empowers companies around the world to connect with their subscribers in trusted and meaningful ways. The company’s collection of products helps streamline networks, simplify onboarding, and engage subscribers to unleash new revenue streams, reduce costs and increase speed to market. Hundreds of millions of subscribers trust Synchronoss products to stay in sync with the people, services, and content they love. That’s why more than 1,500 talented Synchronoss employees worldwide strive each day to reimagine a world in sync. Learn more at www.synchronoss.com.

About Brightspeed

Headquartered in Charlotte, N.C. and expected to have assets and associated operations in 20 states, Brightspeed will provide broadband and telecommunications services through a network platform capable of serving more than six million homes and businesses. The company aims to bridge the digital divide by deploying a state-of-the-art fiber network and a customer experience that makes staying connected simple and seamless. Learn more at www.brightspeed.com.

Synchronoss

Media Relations Contact:
Domenick Cilea
Springboard
dcilea@springboardpr.com

Investor Relations Contact:
Matt Glover / Tom Colton
Gateway Group, Inc.
SNCR@gatewayir.com

Brightspeed

Media Relations Contact:
Erik Carlson
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449
pr@brightspeed.com